Zomedica Statistics
Total Valuation
Zomedica has a market cap or net worth of 104.58 million. The enterprise value is 53.51 million.
| Market Cap | 104.58M |
| Enterprise Value | 53.51M |
Important Dates
The next estimated earnings date is Friday, May 8, 2026.
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Zomedica has 975.54 million shares outstanding.
| Current Share Class | 975.54M |
| Shares Outstanding | 975.54M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.82% |
| Owned by Institutions (%) | 0.13% |
| Float | 946.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.27 |
| PB Ratio | 0.91 |
| P/TBV Ratio | 1.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.65 |
| EV / Sales | 1.67 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.94 |
Financial Position
The company has a current ratio of 6.78, with a Debt / Equity ratio of 0.02.
| Current Ratio | 6.78 |
| Quick Ratio | 6.00 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.12 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -52.63% and return on invested capital (ROIC) is -11.32%.
| Return on Equity (ROE) | -52.63% |
| Return on Assets (ROA) | -10.66% |
| Return on Invested Capital (ROIC) | -11.32% |
| Return on Capital Employed (ROCE) | -24.25% |
| Weighted Average Cost of Capital (WACC) | 12.05% |
| Revenue Per Employee | 227,163 |
| Profits Per Employee | -580,553 |
| Employee Count | 141 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 1.95 |
Taxes
| Income Tax | -278,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +106.08% in the last 52 weeks. The beta is 1.46, so Zomedica's price volatility has been higher than the market average.
| Beta (5Y) | 1.46 |
| 52-Week Price Change | +106.08% |
| 50-Day Moving Average | 0.12 |
| 200-Day Moving Average | 0.09 |
| Relative Strength Index (RSI) | 36.03 |
| Average Volume (20 Days) | 968,517 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.13 |
Income Statement
In the last 12 months, Zomedica had revenue of 32.03 million and -81.86 million in losses. Loss per share was -0.08.
| Revenue | 32.03M |
| Gross Profit | 21.68M |
| Operating Income | -28.52M |
| Pretax Income | -82.14M |
| Net Income | -81.86M |
| EBITDA | -20.57M |
| EBIT | -28.52M |
| Loss Per Share | -0.08 |
Balance Sheet
The company has 53.26 million in cash and 2.18 million in debt, with a net cash position of 51.07 million or 0.05 per share.
| Cash & Cash Equivalents | 53.26M |
| Total Debt | 2.18M |
| Net Cash | 51.07M |
| Net Cash Per Share | 0.05 |
| Equity (Book Value) | 115.40M |
| Book Value Per Share | 0.12 |
| Working Capital | 54.59M |
Cash Flow
In the last 12 months, operating cash flow was -17.65 million and capital expenditures -567,000, giving a free cash flow of -18.22 million.
| Operating Cash Flow | -17.65M |
| Capital Expenditures | -567,000 |
| Depreciation & Amortization | 7.95M |
| Net Borrowing | n/a |
| Free Cash Flow | -18.22M |
| FCF Per Share | -0.02 |
Margins
Gross margin is 67.68%, with operating and profit margins of -89.04% and -255.57%.
| Gross Margin | 67.68% |
| Operating Margin | -89.04% |
| Pretax Margin | -256.43% |
| Profit Margin | -255.57% |
| EBITDA Margin | -64.22% |
| EBIT Margin | -89.04% |
| FCF Margin | n/a |
Dividends & Yields
Zomedica does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -78.27% |
| FCF Yield | -17.42% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Zomedica has an Altman Z-Score of 0.42 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.42 |
| Piotroski F-Score | 2 |